However, Cy treatment enhanced PSD-95 and Synapsin-1 protein levels as well as dendritic spine density, reflecting the involvement of neuroplasticity in the etiology of depression and Cy-related amelioration on depressive symptoms. The gene discussed is DLG4; the disease is depressive symptom measurement.